Panacea Index Logo

Command Palette

Search for a command to run...

Psycho-neuro-endocrino-immunologic issues in multiple sclerosis: a critical review of clinical and therapeutic implications.

Hormones (Athens, Greece)
December 1, 2020
Maria Anagnostouli et al. (3 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to review the impact of melatonin, among other hormones, on the pathophysiology, severity, and comorbid mental disorders in multiple sclerosis (MS).

Results Summary

The abstract mentions melatonin as one of the hormonal components discussed in the context of MS, but specific findings about its effects are not detailed. The focus is on its role in immune dysregulation and disease severity.

Population

Patients with multiple sclerosis (MS).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (18)
InterventionDirectionEndpointPopulationDosageImpactClaim #
glucocorticoids
neutral
immune dysregulation, psychology, and cognitive status
patients with MS
-
have a great impact
#1
estrogens
neutral
immune dysregulation, psychology, and cognitive status
patients with MS
-
have a great impact
#2
prolactin
neutral
immune dysregulation, psychology, and cognitive status
patients with MS
-
have a great impact
#3
dehydroepiandrosterone
neutral
immune dysregulation, psychology, and cognitive status
patients with MS
-
have a great impact
#4
melatonin
neutral
immune dysregulation, psychology, and cognitive status
patients with MS
-
have a great impact
#5
vitamin D
neutral
immune dysregulation, psychology, and cognitive status
patients with MS
-
have a great impact
#6
glucocorticoids
neutral
fertility and response to treatment
patients with MS
-
have a great impact
#7
estrogens
neutral
fertility and response to treatment
patients with MS
-
have a great impact
#8
prolactin
neutral
fertility and response to treatment
patients with MS
-
have a great impact
#9
dehydroepiandrosterone
neutral
fertility and response to treatment
patients with MS
-
have a great impact
#10
melatonin
neutral
fertility and response to treatment
patients with MS
-
have a great impact
#11
vitamin D
neutral
fertility and response to treatment
patients with MS
-
have a great impact
#12
glucocorticoids
neutral
MS pathophysiology, severity of the disease, correlation with comorbid mental disorders, and fertility
-
-
impact
#13
estrogens
neutral
MS pathophysiology, severity of the disease, correlation with comorbid mental disorders, and fertility
-
-
impact
#14
prolactin
neutral
MS pathophysiology, severity of the disease, correlation with comorbid mental disorders, and fertility
-
-
impact
#15
dehydroepiandrosterone
neutral
MS pathophysiology, severity of the disease, correlation with comorbid mental disorders, and fertility
-
-
impact
#16
melatonin
neutral
MS pathophysiology, severity of the disease, correlation with comorbid mental disorders, and fertility
-
-
impact
#17
vitamin D
neutral
MS pathophysiology, severity of the disease, correlation with comorbid mental disorders, and fertility
-
-
impact
#18
Abstract

Multiple sclerosis (MS) is a multifactorial, chronic, immune-mediated, and neurodegenerative disease, having a well-known hypothalamic-pituitary-adrenal (HPA) axis dysfunction. Several hormones have a great impact in the immune dysregulation, psychology, and cognitive status of patients with MS, as also in the fertility and response to treatment. In this comprehensive review, as an introduction, we mention basic data concerning MS: epidemiology, genetics, immunogenetics, epigenetics, pathophysiology, and neuroimmunology. Hormonal components of the disease cascade, mainly glucocorticoids (stress-related hormone), estrogens, prolactin and dehydroepiandrosterone (sex-related hormones), melatonin, and vitamin D, are discussed, aiming at focusing on core data regarding the impact of these hormones in MS pathophysiology, severity of the disease, correlation with comorbid mental disorders, and fertility. A great focus is given in the pre- and post-pregnancy period of MS patients, in the context of the disease-modifying treatments (DMTs) and HPA status, having in mind that there are only very limited knowledge and few papers on this specific life period of these women, having MS. All this data are presented in the main text and also in the workable tables, for the first time, suggesting targeted topics that need to be addressed in the near future.

Medical Subject Headings (MeSH)
FemaleHumansImmunologic FactorsMultiple SclerosisPregnancyPregnancy Complications
Study Links
Quality Scores
SafetyNot Assessed
Efficacy65/10
Quality75/10
Citation Metrics
Total Citations15
Citations/Year3.0
Relative Citation Ratio1.14
NIH Percentile55%
Research Impact Scores
APT Score0.75
Weight Score2.29
Normalized Score0.61
Related Supplements